| Bronchogenic Carcinoma studied in …STUDIED_INderived35 of 35show fewer |
|---|
| → studied in | NCT06494241active not recruiting Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study · condition mapped ALIAS · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06376084active not recruiting Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06971848NA · recruiting Evaluation of Skin Tests in Biotherapy Allergies · condition mapped ALIAS · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03684486NA · terminated Rehabilitation by Effort for Patients With Advanced Bronchial Cancer · condition mapped PROBABILISTIC · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04222972Phase 3 · terminated A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06841874no longer available Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03786653completed Feasibility of Immunotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home Setting (ImHADom) · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03037385Phase 1/Phase 2 · completed Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04862780Phase 1 · terminated (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05241873Phase 1 · terminated (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06564870unknown Efficacy and Safety Study of DURVALUMAB Maintenance in Patients With Stage III Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04802902completed Feasibility of Immunotherapy Plus Chemotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home Setting · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06177925Phase 2 · recruiting A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05605236completed Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0) · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04989283Phase 2 · withdrawn Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Superior Sulcus Lung Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04644315Phase 2 · terminated A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05153408Phase 1 · terminated (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03085069Phase 2 · unknown A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03328559NA · completed Kinetics of Circulating Tumoral Cells in Bronchial Primitive Cancer · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04697446unknown External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03402048Phase 3 · unknown The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04517019NA · unknown Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy · condition mapped ALIAS · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03134872Phase 3 · completed A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03331588Phase 3 · completed Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung Cancer · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00652769Phase 3 · completed A New Pathway With BronchOscopic or Oesophageal Ultrasound for Lung Cancer Diagnosis and STaging (BOOST) · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02441972Phase 1 · unknown Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02804100unknown Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02877043unknown Study of the Quality of Lung Resection · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02270853NA · unknown SAS in Patients With Bronchial Carcinoma · condition mapped ALIAS · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02648087NA · unknown Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01058785Phase 2 · completed Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00102505Phase 1 · completed A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC) · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00196885Phase 2 · completed Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training · condition mapped ALIAS · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001515Phase 1 · completed Diagnostic Effectiveness of Virtual Bronchoscopy · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00407264Phase 2 · completed Randomized Trial of Fluticasone in Bronchial Premalignancy · condition mapped ONTOLOGY_EXACT · 35 trials mapped (4 active) | — | — | Bronchogenic Carcinoma | 1 | Observed | clinicaltrials | graph → |